Sector Chart Interpace Biosciences, Inc.

Stocks

IDXG

US46062X3035

Healthcare Facilities & Services

Delayed OTC Markets Other stock markets 09:32:51 2026-06-15 EDT			5-day change	1st Jan Change
1.650 ^USD	+3.12%		-1.79%	+34.12%

05-12	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-30	Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Medical & Diagnostic Laboratories

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
INTERPACE BIOSCIENCES, INC.	44.32M	-	-	-	-	-
NATERA, INC.	30.37B					-
SONIC HEALTHCARE LIMITED	7.04B
RADNET, INC.	4.46B			-	-
DR. LAL PATHLABS LIMITED	2.82B
DIAN DIAGNOSTICS GROUP CO.,LTD.	1.79B